| Host: |
Rabbit |
| Applications: |
IHC/IF/ELISA |
| Reactivity: |
Human/Rat/Mouse |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Rabbit polyclonal antibody anti-Ecto-ADP-ribosyltransferase 4transferase 4+--arginine ADP-ribosyltransferase 4 (181-230 aa) is suitable for use in Immunohistochemistry, Immunofluorescence and ELISA research applications. |
| Clonality: |
Polyclonal |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG |
| Formulation: |
Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide. |
| Purification: |
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
| Concentration: |
1 mg/mL |
| Dilution Range: |
IHC-P 1:50-200ELISA 1:10000-20000IF 1:50-200 |
| Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Gene Symbol: |
ART4 |
| Gene ID: |
420 |
| Uniprot ID: |
NAR4_HUMAN |
| Immunogen Region: |
181-230 aa |
| Specificity: |
The antibody detects endogenous CD297 |
| Immunogen: |
Synthetic peptide from the human protein at the amino acid range 181-230 |
| Protein Name | Ecto-Adp-Ribosyltransferase 4Adp-Ribosyltransferase C2 And C3 Toxin-Like 4Artc4Dombrock Blood Group Carrier MoleculeMono(Adp-Ribosyltransferase 4Nad(P(+--Arginine Adp-Ribosyltransferase 4Cd Antigen Cd297 |
| Database Links | Reactome: R-HSA-163125 |
| Cellular Localisation | Cell MembraneLipid-AnchorGpi-Anchor |
| Alternative Antibody Names | Anti-Ecto-Adp-Ribosyltransferase 4 antibodyAnti-Adp-Ribosyltransferase C2 And C3 Toxin-Like 4 antibodyAnti-Artc4 antibodyAnti-Dombrock Blood Group Carrier Molecule antibodyAnti-Mono(Adp-Ribosyltransferase 4 antibodyAnti-Nad(P(+--Arginine Adp-Ribosyltransferase 4 antibodyAnti-Cd Antigen Cd297 antibodyAnti-ART4 antibodyAnti-DO antibodyAnti-DOK1 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
